Trace Neuroscience is a Biotech company based in South San Francisco. It has raised $101M in total funding. Latest round: Series A.
Trace Neuroscience is a Biotech company based in South San Francisco. Trace Neuroscience has raised $101M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in November 2024. The round record for Trace Neuroscience runs through 2024; nothing later has been disclosed. Investors on record include Third Rock Ventures, Atlas Venture, GV, RA Capital Management. 4 distinct backers are named across the disclosed rounds.
Trace Neuroscience totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in South San Francisco below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026